Procurement Summary
Country: USA
Summary: Compound Library For Nutraceutical Research
Deadline: 25 May 2017
Posting Date: 23 May 2017
Other Information
Notice Type: Tender
TOT Ref.No.: 13347504
Document Ref. No.: HHS-NIH-NIDA-SSSA-SS-2017-357
Competition: ICB
Financier: Self Financed
Purchaser Ownership: -
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
This is a sources sought notice. This is not a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding the availability and capability of all qualified sources to perform a potential requirement.
This notice is issued to help determine the availability of qualified companies technically capable of meeting the government requirement and to determine the method of acquisition. It is not to be construed as a commitment by the government to issue a solicitation or ultimately award a contract. Responses will not be considered as proposals or quotes. No award will be made as a result of this notice. The government will not be responsible for any costs incurred by the respondents to this notice. This notice is strictly for research and information purposes only.
Background: the national institutes of health (nih) is the nation s leading medical research agency and the primary federal agency whose mission is to seek fundamental knowledge about the nature and behavior of living systems. The application of this knowledge is to enhance health, lengthen life, and reduce illness and disability, conducting, supporting and making medical discoveries that improve people s health and save lives.
The national center for advancing translational sciences (ncats) is a part of the national institutes of health (nih), which mission it is to catalyze the generation of innovative methods and technologies that will enhance the development, testing and implementation of diagnostics and therapeutics across a wide range of human diseases and conditions.
Screening is often the starting point in ncats development and a wealth of knowledge is obtained from screening a diverse collection. It provides the starting point of all information for medicinal chemistry s structure-activity relationship (sar) design to synthesize novel compounds that have more desirable properties. A diverse and novel screening collect...
Documents
Tender Notice